As AURKA overexpression is also associated with enhanced chemoresistance, we hypothesized that AURKA may upregulate ALDH1A1 leading to EMT, CSC phenotypes, and chemoresistance in pancreatic cancer. This evidence concerns the gene AURKA and pancreatic neoplasm.